Mutant-selective irreversible EGFR inhibitor, naquotinib,...

  • Main
  • 2019 / 05
  • Mutant-selective irreversible EGFR inhibitor, naquotinib,...
Molecular Cancer Therapeutics 2019 / 05

Mutant-selective irreversible EGFR inhibitor, naquotinib, inhibits tumor growth in NSCLC models with EGFR activating mutations, T790M mutation and AXL overexpression

Tanaka, Hiroaki, Sakagami, Hideki, Kaneko, Naoki, Konagai, Satoshi, Yamamoto, Hiroko, Matsuya, Takahiro, Yuri, Masatoshi, Yamanaka, Yosuke, Mori, Masamichi, Takeuchi, Masahiro, Koshio, Hiroyuki, Hiran
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-18-0976
Date:
May, 2019
File:
PDF, 2.35 MB
english, 2019
Conversion to is in progress
Conversion to is failed